An Open-Label Phase 1b Study Evaluating the Safety, Tolerability, Immunogenicity and Antiviral Activity of Multiple Doses of CLB-3000 in Subjects with Chronic Hepatitis B

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • McKenzie, Jo (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date2/08/23 → 1/08/25

Keywords

  • Clinical trial
  • CLB-3000-1-001